Generation of Endothelial Cell Memory in Inflammatory Vascular Disease
炎症性血管疾病中内皮细胞记忆的产生
基本信息
- 批准号:10671561
- 负责人:
- 金额:$ 16.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-27 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:Abnormal Endothelial CellAcuteAddressAnimal ModelAnti-Inflammatory AgentsAntigensApoptosisApoptoticAreaBlood VesselsBrazilCaveolinsCell DeathCell Death InductionCell SurvivalCell secretionCellsCessation of lifeCharacteristicsChicagoChronicChronic Lung InjuryCollaborationsCommunitiesCreativenessCultural BackgroundsCuriositiesCytometryCytoprotectionDataDedicationsDevelopmentDevelopment PlansDiseaseDoctor of PhilosophyEndothelial CellsEndotheliumEnvironmentEvaluationFacultyFibrosisFunctional disorderGenerationsGoalsGrowthHumanIllinoisImmuneImmunityImmunobiologyImpairmentIn VitroInduction of ApoptosisInfectionInflammationInflammatoryInjuryInstitutionKnowledgeLeadershipLearningLesionLifeLungLymphocyteMediatingMemoryMentorsMethodologyModelingMolecular TargetMusParasitesParasitic infectionPersonsPharmacologyPhasePhenotypePhosphorylationProcessProliferatingPulmonary FibrosisPulmonary Heart DiseasePulmonary InflammationPulmonary vesselsReportingResearchResearch PersonnelResearch Project SummariesResearch SubjectsResistanceScaffolding ProteinSchistosoma mansoniSchistosoma mansonii infectionSignal TransductionSmooth Muscle MyocytesStudentsTechnical ExpertiseTestingTh2 CellsTherapeutic EmbolizationTissuesTrainingTransforming Growth Factor betaUniversitiesVascular DiseasesVascular ProliferationVascular remodelingVesicleVoiceWomancareercareer developmentcaveolin 1chemokineclinical developmentcytokinedistinguished professoreggexperiencehypertension treatmentimprintin vivoinhibitorinhibitor of apoptosis protein 2injuredinsightinter-institutionallectureslung pressuremolecular modelingnoveloverexpressionpathogenpharmacologicpre-clinicalpreventpulmonary arterial hypertensionreceptorrecruitresponseskillssuccesssuperresolution microscopytargeted treatment
项目摘要
Summary of the Research Project: Pulmonary arterial hypertension (PAH) is a life-threatening disease with
no cure
characterized by severe lesions in the pulmonary vessels due to hyperproliferation of vascular cells,
including endothelial cells. The primary cause of these lesions is largely unknown, but several studies indicate
they result from chronic inflammation, such as that caused by Schistosoma mansoni infection. ~10 million people
infected with S. mansoni develop PAH (Sch-PAH). Thus, a better understanding of how the infection promotes
the formation of vascular lesions will provide insights for identifying novel molecular targets for PAH treatment.
Recently, we reported that endothelial cells that survive to chronic lung injury, show reduced expression of the
anti-proliferative scaffolding protein caveolin-1 (Cav-1) and elevated response to pro-fibrotic TGF-β signaling.
Activation of TGF-β requires recruitment of Th2 cells into the lungs, which in turn expands Cav-1 depleted
endothelial cells and promote PAH. Although it is unknown how Cav-1-depleted endothelial cells contribute to
Sch-PAH, our preliminary data indicate enhanced expression of inhibitor of apoptosis protein 2 (c-IAP2) may
participate in this process. In line with this observation, data suggest that S. mansoni-primed endothelial cells
retain in vitro a memory of the in vivo infection. Specifically, this memory is characterized by impaired function
of the death associated receptor P2X7, which is controlled by Cav-1 expression. Thus, I hypothesize that while
S. mansoni infection leads to lung endothelial cell death and secretion of c-IAP2, recipient cells generate a long-
lasting survival memory required for endothelial-immune cell crosstalk and the development of Sch-PAH.
Candidate & Institutional Environment: Dr. Oliveira is Junior Faculty at the University of Illinois at Chicago
(UIC). She earned her Ph.D. in Immunobiology and M.Sc. in Pharmacology from the Federal University of Rio
de Janeiro, Brazil. As a Latin woman, she grew up surrounded by different cultural backgrounds, and thus,
learned how diversity is a crucial part of the human experience and existence itself. Dr. Oliveira’s career
development plan combines the knowledge and technical expertise from her graduate and post-graduate training
with novel methodologies and research subjects to build up a unique trajectory toward becoming a fully
independent investigator. Specifically, Dr. Oliveira proposes advancing her leadership skills, strengthening her
inter-institutional network, providing and organizing lectures inside and outside of her institution, and further
engaging in mentoring and student evaluation. To achieve these goals, Dr. Oliveira built a team with
distinguished Professors from the areas of expertise needed for both the scientific and professional success of
her career development plan. In terms of the environment, Dr. Oliveira is located in an acclaimed research
institution dedicated to discovering and distributing knowledge. Thus, along with her professional growth, Dr.
Oliveira plans to promote the growth of the academic community as a whole by engaging all voices into an
inclusive and creative environment required for continuous scientific progress and institutional excellence.
研究项目的摘要:肺动脉高压(PAH)是一种威胁生命的疾病
无法治愈
由于血管细胞的过度增殖,其特征是肺部视频中的严重病变,
包括内皮细胞。这些病变的主要原因在很大程度上是未知的,但几项研究表明
它们是由慢性感染引起的,例如由曼森血吸虫感染引起的。 〜1000万人
感染了S. Mansoni发展PAH(Sch-Pah)。这是对感染如何促进的更好理解
血管病变的形成将为鉴定新的分子靶标提供见解。
最近,我们报道了生存为慢性肺损伤的内皮细胞,显示出降低的表达
抗增殖的脚手架蛋白小窝蛋白1(CAV-1)和对纤维化TGF-β信号的反应升高。
TGF-β的激活需要将Th2细胞募集到肺部,进而扩展Cav-1耗尽
内皮细胞并促进PAH。尽管尚不清楚Cav-1缺乏的内皮细胞有助于
Sch-Pah,我们的初步数据表明凋亡蛋白2(C-IAP2)的抑制剂表达增强了
参加此过程。与此观察一致,数据表明S. mansoni-primed内皮细胞
保留体内感染的体外记忆。具体而言,此内存的特征是功能受损
与死亡相关的接收器P2X7的控制,该接收器由CAV-1表达控制。那我假设
曼氏链球菌感染导致肺内皮细胞死亡和C-IAP2的分泌,受体细胞会产生长期
内皮免疫细胞串扰和Sch-Pah的发展所需的持久存活记忆。
候选人与机构环境:Oliveira博士是伊利诺伊大学芝加哥大学的初级教师
(UIC)。她获得了博士学位在免疫生物学和硕士学位里约联邦大学的药理学
巴西的德·贾尼罗(De Janeiro)。作为拉丁女人,她长大了,被不同的文化背景所包围,因此
了解了人类经验和生存本身的重要组成部分多样性。奥利维拉博士的职业
发展计划结合了她的研究生和研究生培训的知识和技术专长
通过新颖的方法和研究对象,建立了独特的轨迹,以成为一个完全
独立研究者。特别是,奥利维拉博士的提议提高了她的领导能力,增强了她
机构间网络,在其机构内外提供和组织讲座,并进一步
从事心理和学生评估。为了实现这些目标,奥利维拉博士与
杰出的教授与科学和专业成功所需的专业知识领域
她的职业发展计划。在环境方面,奥利维拉博士位于一项广受赞誉的研究中
致力于发现和分发知识的机构。随着她的专业成长,博士
奥利维拉(Oliveira)计划通过使所有声音参与整个学术界的成长
持续的科学进步和机构卓越所需的包容性和创造性环境。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cardiopulmonary Pathogenic Networks: Unveiling the Gut-Lung Microbiome Axis in Pulmonary Arterial Hypertension.
- DOI:10.1164/rccm.202211-2126ed
- 发表时间:2023-03-15
- 期刊:
- 影响因子:24.7
- 作者:Oliveira, Suellen Darc
- 通讯作者:Oliveira, Suellen Darc
Schistosomiasis-associated pulmonary hypertension unveils disrupted murine gut-lung microbiome and reduced endoprotective Caveolin-1/BMPR2 expression.
- DOI:10.3389/fimmu.2023.1254762
- 发表时间:2023
- 期刊:
- 影响因子:7.3
- 作者:Marinho, Ygor;Villarreal, Elizabeth S.;Aboagye, Sammy Y.;Williams, David L.;Sun, Jun;Silva, Claudia L. M.;Lutz, Sarah E.;Oliveira, Suellen D.
- 通讯作者:Oliveira, Suellen D.
Thiostrepton-Nanomedicine, a TLR9 Inhibitor, Attenuates Sepsis-Induced Inflammation in Mice.
- DOI:10.1155/2023/4035516
- 发表时间:2023
- 期刊:
- 影响因子:4.6
- 作者:Esparza, K.;Oliveira, S. D.;Castellon, M.;Minshall, R. D.;Onyuksel, H.
- 通讯作者:Onyuksel, H.
Insights on the Gut-Mesentery-Lung Axis in Pulmonary Arterial Hypertension: A Poorly Investigated Crossroad.
- DOI:10.1161/atvbaha.121.316236
- 发表时间:2022-05
- 期刊:
- 影响因子:8.7
- 作者:Oliveira, Suellen Darc
- 通讯作者:Oliveira, Suellen Darc
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Suellen D'Arc dos Santos Oliveira其他文献
Suellen D'Arc dos Santos Oliveira的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Suellen D'Arc dos Santos Oliveira', 18)}}的其他基金
Generation of Endothelial Cell Memory in Inflammatory Vascular Disease
炎症性血管疾病中内皮细胞记忆的产生
- 批准号:
10282954 - 财政年份:2021
- 资助金额:
$ 16.2万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Generation of Endothelial Cell Memory in Inflammatory Vascular Disease
炎症性血管疾病中内皮细胞记忆的产生
- 批准号:
10282954 - 财政年份:2021
- 资助金额:
$ 16.2万 - 项目类别:
Bone Marrow Niche dysfunction in sickle cell disease
镰状细胞病的骨髓生态位功能障碍
- 批准号:
10250697 - 财政年份:2021
- 资助金额:
$ 16.2万 - 项目类别:
Development of an irreversible covalent inhibitor of FMS-like tyrosine kinase receptor 3 for treating acute myeloid leukemia
开发用于治疗急性髓性白血病的 FMS 样酪氨酸激酶受体 3 的不可逆共价抑制剂
- 批准号:
10081364 - 财政年份:2020
- 资助金额:
$ 16.2万 - 项目类别:
Endothelial cell transplantation for multi-organ repair to counter radiation injury
内皮细胞移植用于多器官修复以对抗辐射损伤
- 批准号:
9904499 - 财政年份:2018
- 资助金额:
$ 16.2万 - 项目类别:
Endothelial cell transplantation for multi-organ repair to counter radiation injury
内皮细胞移植用于多器官修复以对抗辐射损伤
- 批准号:
10381505 - 财政年份:2018
- 资助金额:
$ 16.2万 - 项目类别: